Connection
Cynthia Epperson to Dopamine Antagonists
This is a "connection" page, showing publications Cynthia Epperson has written about Dopamine Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.019 |
|
|
|
-
McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000 Aug; 57(8):794-801.
Score: 0.011
-
Carpenter LL, McDougle CJ, Epperson CN, Price LH. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug Saf. 1996 Aug; 15(2):116-34.
Score: 0.008